Vaccination and chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 23, Issue 3, 2008, Pages 800-807

  Janus, Nicolas ^a   Vacher, Launay Vincent ^a   Karie, Svetlana ^a   Ledneva, Elena ^a   Deray, Gilbert ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Chronic kidney disease; Vaccination

Indexed keywords

CHICKENPOX VACCINE; CYTOKINE; DIPHTHERIA POLIOMYELITIS TETANUS VACCINE; ERYTHROPOIETIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; IMMUNOMODULATING AGENT; INFLUENZA VACCINE; INTERFERON; LEVAMISOLE; MEASLES MUMPS RUBELLA VACCINE; POLIOMYELITIS VACCINE; RECOMBINANT HEPATITIS B VACCINE; STAPHYLOCOCCUS VACCINE; THYMOPENTIN; YELLOW FEVER VACCINE; ZINC; IMMUNOLOGICAL ADJUVANT;

ANTIBODY RESPONSE; ANTIBODY TITER; BACTEREMIA; BACTERIAL INFECTION; CHRONIC KIDNEY DISEASE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; INFECTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS INFECTION; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; DOSE RESPONSE; IMMUNOLOGY; KIDNEY DISEASE;

ADJUVANTS, IMMUNOLOGIC; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; VACCINATION;

EID: 42449133842     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm851     Document Type: Editorial

References (59)

1. van Dijk PC, Jager KJ, de Charro F et al. Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant 2001; 16: 1120-1129
2. Johnson DW, Fleming SJ. The use of vaccines in renal failure. Clin Pharmacokinet 1992; 22: 434-446
3. Tokars JI, Miller ER, Alter MJ et al. National surveillance of dialysis associated diseases in the United States, 1995. Asaio J 1998; 44: 98-107
4. Fabrizi F, Martin P. Hepatitis B vaccine and dialysis: current issues. Int J Artif Organs 2001; 24: 683-694
5. Kara IH, Yilmaz ME, Suner A et al. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients. Vaccine 2004; 22: 3963-3967
6. Liu YL, Kao MT, Huang CC. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis. Vaccine 2005; 23: 3957-3960
7. Bel'eed K, Wright M, Eadington D et al. Vaccination against hepatitis B infection in patients with end stage renal disease. Postgrad Med J 2002; 78: 538-540
8. Charest AF, McDougall J, Goldstein MB. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Am J Kidney Dis 2000; 36: 976-982
9. DaRoza G, Loewen A, Djurdjev O et al. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better. Am J Kidney Dis 2003; 42: 1184-1192
10. McNulty CA, Bowen JK, Williams AJ. Hepatitis B vaccination in predialysis chronic renal failure patients a comparison of two vaccination schedules. Vaccine 2005; 23: 4142-4147
11. Jadoul M, Goubau P. Is anti-hepatitis B virus (HBV) immunization successful in elderly hemodialysis (HD) patients? Clin Nephrol 2002; 58: 301-304
12. Dukes CS, Street AC, Starling JF et al. Hepatitis B vaccination and booster in predialysis patients: a 4-year analysis. Vaccine 1993; 11: 1229-1232
13. Fisman DN, Agrawal D, Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis 2002; 35: 1368-1375
14. Centers for Disease Control and Prevention. Recommandations for preventing transmission of infections among chronic hemodialysis patients. MMWR 2001; 50: 25
15. Rangel MC, Coronado VG, Euler GL et al. Vaccine recommendations for patients on chronic dialysis. The Advisory Committee on Immunization Practices and the American Academy of Pediatrics. Semin Dial 2000; 13: 101-107
16. Dinits-Pensy M, Forrest GN, Cross AS et al. The use of vaccines in adult patients with renal disease. Am J Kidney Dis 2005; 46: 997-1011
17. Tong NK, Beran J, Kee SA et al. Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients. Kidney Int 2005; 68: 2298-2303
18. Fleischmann EH, Kruppenbacher J, Bock HL, et al. Active immunization against hepatitis A in dialysis patients. Nephrol Dial Transplant 2002; 17: 1825-1828
19. Kuramoto I, Fujiyama S, Matsushita K et al. Immune response after hepatitis A vaccination in haemodialysis patients: comparison with hepatitis B vaccination. J Gastroenterol Hepatol 1994; 9: 228-231
20. Webb NJ, Fitzpatrick MM, Hughes DA et al. Immunisation against varicella in end stage and pre-end stage renal failure. Trans-Pennine Paediatric Nephrology Study Group. Arch Dis Child 2000; 82: 141-143
21. Furth SL, Hogg RJ, Tarver J, et al. Varicella vaccination in children with chronic renal failure. A report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol 2003; 18: 33-38
22. Broyer M, Tete MJ, Guest G et al. Varicella and zoster in children after kidney transplantation: long-term results of vaccination. Pediatrics 1997; 99: 35-39
23. Simonsen L, Clarke MJ, Williamson GD et al. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1997; 87: 1944-1950
24. Gilbertson DT, Unruh M, McBean AM et al. Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int 2003; 63: 738-743
25. Antonen JA, Hannula PM, Pyhala R et al. Adequate seroresponse to influenza vaccination in dialysis patients. Nephron 2000; 86: 56-61
26. Antonen JA, Pyhala R, Hannula PM et al. Influenza vaccination of dialysis patients: cross-reactivity of induced haemagglutination-inhibiting antibodies to H3N2 subtype antigenic variants is comparable with the response of naturally infected young healthy adults. Nephrol Dial Transplant 2003; 18: 777-781
27. Vogtlander NP, Brown A, Valentijn RM et al. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients. Vaccine 2004; 22: 2199-2201
28. Cavdar C, Sayan M, Sifil A et al. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients. Scand J Urol Nephrol 2003; 37: 71-76
29. Neu AM, Lederman HM, Warady BA et al. Haemophilus influenzae type b immunization in infants on peritoneal dialysis. Pediatric Peritoneal Dialysis Study Consortium. Pediatr Nephrol 1996; 10: 84-85
30. Schulman SL, Deforest A, Kaiser BA et al. Response to measles-mumps-rubella vaccine in children on dialysis. Pediatr Nephrol 1992; 6: 187-189
31. Sipila R, Hortling L, Hovi T. Good seroresponse to enhanced-potency inactivated poliovirus vaccine in patients on chronic dialysis. Nephrol Dial Transplant 1990; 5: 352-355
32. Kessler M, Hoen B, Mayeux D et al. Bacteremia in patients on chronic hemodialysis. A multicenter prospective survey. Nephron 1993; 64: 95-100
33. Welch PG, Fattom A, Moore J Jr et al. Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis. J Am Soc Nephrol 1996; 7: 247-253
34. Fattom A, Fuller S, Propst M et al. Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients. Vaccine 2004; 23: 656-663
35. Shinefield H, Black S, Fattom A et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 2002; 346: 491-496
36. Girndt M, Pietsch M, Kohler H. Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure. Am J Kidney Dis 1995; 26: 454-460
37. Guerin A, Buisson Y, Nutini MT et al. Response to vaccination against tetanus in chronic haemodialysed patients. Nephrol Dial Transplant 1992; 7: 323-326
38. Kruger S, Muller-Steinhardt M, Kirchner H et al. A 5-year follow-up on antibody response after diphtheria and tetanus vaccination in hemodialysis patients. Am J Kidney Dis 2001; 38: 1264-1270
39. Linnemann CC Jr, First MR, Schiffman G. Response to pneumococcal vaccine in renal transplant and hemodialysis patients. Arch Intern Med 1981; 141: 1637-1640
40. Fuchshuber A, Kuhnemund O, Keuth B et al. Pneumococcal vaccine in children and young adults with chronic renal disease. Nephrol Dial Transplant 1996; 11: 468-473
41. Furth SL, Neu AM, Case B et al. Pneumococcal polysaccharide vaccine in children with chronic renal disease: a prospective study of antibody response and duration. J Pediatr 1996; 128: 99-101
42. Biggar RJ, Goedert JJ, Hoofnagle J. Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV. N Engl J Med 1987; 316: 630-631
43. Rey D, Krantz V, Partisani M et al. Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load. Vaccine 2000; 18: 1161-1165
44. Opravil M, Fierz W, Matter L et al. Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients. Clin Exp Immunol 1991; 84: 185-189
45. Ahuja TS, Kumar S, Mansoury H et al. Hepatitis B vaccination in human immunodeficiency virus-infected adults receiving hemodialysis. Kidney Int 2005; 67: 1136-1141
46. Ahuja TS, O'Brien WA. Special issues in the management of patients with ESRD and HIV infection. Am J Kidney Dis 2003; 41: 279-291
47. Mandayam S, Ahuja TS. Dialyzing a patient with human immunodeficiency virus infection: what a nephrologist needs to know. Am J Nephrol 2004; 24: 511-521
48. Ericsson CD. Travellers with pre-existing medical conditions. Int J Antimicrob Agents 2003; 21: 181-188
49. Fabrizi F, Ganeshan SV, Dixit V et al. Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease. Aliment Pharmacol Ther 2006; 24: 789-796
50. Cruciani M, Mengoli C, Serpelloni G et al. Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination: a meta-analysis. Vaccine 2007; 25: 709-718
51. Kayatas M. Levamisole treatment enhances protective antibody response to hepatitis B vaccination in hemodialysis patients. Artif Organs 2002; 26: 492-496
52. Argani H, Akhtarishojaie E. Levamizole enhances immune responsiveness to intra-dermal and intra-muscular hepatitis B vaccination in chronic hemodialysis patients. J Immune Based Ther Vaccines 2006; 4: 3
53. Deniz Ayli M, Ensari C, Ayli M et al. Effect of oral levamisole supplementation to hepatitis B vaccination on the rate of immune response in chronic hemodialysis patients. Nephron 2000; 84: 291-292
54. Dumann H, Meuer SC, Renschin G et al. Influence of thymopentin on antibody response, and monocyte and T cell function in hemodialysis patients who fail to respond to hepatitis B vaccination. Nephron 1990; 55: 136-140
55. Ervo R, Faletti P, Magni S et al. Evaluation of treatments for the vaccination against hepatitis B + thymopentine. Nephron 1992; 61: 371-372
56. Fabrizi F, Dixit V, Bunnapradist S et al. Meta-analysis: the dialysis mode and immunological response to hepatitis B virus vaccine in dialysis population. Aliment Pharmacol Ther 2006; 23: 1105-1112
57. Blumberg EA, Albano C, Pruett T et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 1996; 22: 295-302
58. Watkins SL, Alexander SR, Brewer ED et al. Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure. Am J Kidney Dis 2002; 40: 365-372
59. Waite E, Laraque D. Pediatric organ transplant patients and long-term care: a review. Mt Sinai J Med 2006; 73: 1148-1155